Shares of PB Fintech Ltd. slid 5.8% to ₹1,084.5 on Tuesday, as Bernstein slashed its price target by 53%, cutting it from ₹2,310 to ₹1,085 while keeping an "outperform" rating.\n
The cut follows the IRDAI’s draft guidelines, which could trim commissions by 50‑66% in health, motor and term lines, a hit that Bernstein says erodes PB Fintech’s take rates to a level that can’t cover current costs.\n
Bernstein warned the company faces a "do‑or‑die" window over the next 18 months as it may either pull back from general insurance, pivot to life‑insurance, or seek new revenue models.\n
Other houses have mirrored the bearish tilt: HSBC and Motilal Oswal trimmed their targets to ₹1,150, Investec cut ₹2,500 to ₹1,425, while 25 analysts cover the stock—15 buy, 6 hold, 4 sell.\n
The share has been down 42.2% in the past month and has lost four straight sessions since the IRDAI draft hit the market, underscoring the sector’s sensitivity to regulatory tightening.\n
With guidance still pending and the industry under pressure, investors will watch PB Fintech’s next earnings for clues on whether it can sustain growth amid a shrinking commission landscape.